IBEX (IBEX) YoY EBITDA Growth: 16.12% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IBEX IBEX Ltd IBEX
77 GF Score
Price $36.35
GF Value $30.62
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is IBEX YoY EBITDA Growth?

IBEX IBEX +0.30% 77 YoY EBITDA Growth is 16.12% as of Mar. 2026. GuruFocus rates IBEX with a GF Score™ of 77/100 and a GF Value™ of $30.62 (Modestly Overvalued). The stock has 1 warning sign investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. IBEX's YoY EBITDA Growth for the quarter that ended in Mar. 2026 was 16.12%.

IBEX's EBITDA per Share for the three months ended in Mar. 2026 was $1.43.

IBEX YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for IBEX's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IBEX YoY EBITDA Growth Chart

IBEX Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -31.60 21.98 53.67 4.97 23.42

IBEX Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.62 11.75 54.30 35.86 16.12
IBEX
77GF Score
IBEX Ltd IBEX
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IBEX YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

IBEX's YoY EBITDA Growth for the fiscal year that ended in Jun. 2025 is calculated as:

YoY EBITDA Growth (A: Jun. 2025 )
=(EBITDA per Share (A: Jun. 2025 )-EBITDA per Share (A: Jun. 2024 ))/ | EBITDA per Share (A: Jun. 2024 ) |
=(4.121-3.339)/ | 3.339 |
=23.42 %

IBEX's YoY EBITDA Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (Q: Mar. 2026 )
=(EBITDA per Share (Q: Mar. 2026 )-EBITDA per Share (Q: Mar. 2025 )) / | EBITDA per Share (Q: Mar. 2025 )) |
=(1.426-1.228)/ | 1.228 |
=16.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 16.12% mean?
IBEX (IBEX) has a YoY EBITDA Growth of 16.12% as of Mar. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for IBEX and its competitors.
Is IBEX's YoY EBITDA Growth too high?
IBEX's current YoY EBITDA Growth is 16.12%. Overall, IBEX has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IBEX's YoY EBITDA Growth compare to GDYN and FCCN?
IBEX's YoY EBITDA Growth of 16.12% can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Software company?
A good YoY EBITDA Growth depends on the Software industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for IBEX and its competitors. IBEX's current YoY EBITDA Growth is 16.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IBEX stock overvalued right now?
Based on GuruFocus' analysis, IBEX (IBEX) is currently considered Modestly Overvalued. The stock's GF Value™ is $30.62, compared to a current price of $36.35 — trading 18.7% above its estimated fair value. The current YoY EBITDA Growth is 16.12%. IBEX's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For IBEX (IBEX), the current YoY EBITDA Growth is 16.12% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IBEX (IBEX) Overvalued in 2026?

Based on GuruFocus' analysis, IBEX stock appears to be overvalued. The current stock price of $36.35 is trading 18.7% above its estimated GF Value™ of $30.62. GuruFocus considers IBEX to be Modestly Overvalued.

Key valuation signals for IBEX:

  • YoY EBITDA Growth: 16.12%
  • GF Value™: $30.62 vs. price of $36.35 (18.7% above fair value)
  • GF Score™: 77/100 with 1 warning sign

No single metric tells the full story. See the IBEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IBEX Business Description

Other Exchanges IB7:Germany
Address 1717 Pennsylvania Avenue NW, Suite 825, Washington DC, WA, USA, 20006
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.
77GF Score

Get the complete analysis for IBEX

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$36.35
Price
$30.62
GF Value